Performance analysis of VistaGen Therapeutics (VTGN)
Annual Return
Over the past 3 years, VTGN has had an average annual return of -50.28%, underperforming the benchmark SPY, which returned +19.31% annual.
Over the past 5 years, VTGN has had an average annual return of -69.55%, underperforming the benchmark SPY, which returned +12.78% annual.
Over the past 10 years, VTGN has had an average annual return of -45.94%, underperforming the benchmark SPY, which returned +14.91% annual.
Since May 6, 2016, VTGN has had an average annual return of -48.68%, underperforming the benchmark SPY, which returned +15.25% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -65.63% | -77.14% | -42.86% | +66.67% | -94.72% | +0.54% | +181.03% | -53.99% | +35.12% | -70.24% | -46.71% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -15.63% | +3.70% | -3.57% | +7.41% | +3.45% | -63.33% | +0% | -65.63% | |||||
| 2025 | -1.43% | -6.52% | -7.75% | -6.72% | +10.81% | -22.76% | +44.21% | +16.06% | +6.29% | +11.24% | +23.94% | -86.27% | -77.14% |
| 2024 | -6.94% | +6.58% | +3.29% | -8.37% | -20.00% | -9.78% | -1.81% | +1.84% | -13.86% | +2.80% | -8.16% | +3.70% | -42.86% |
| 2023 | +151.70% | -32.16% | -29.08% | +12.36% | +1.50% | -56.16% | -2.25% | +191.95% | -1.57% | -39.60% | +13.25% | +43.27% | +66.67% |
| 2022 | -16.40% | -14.13% | -11.45% | +2.43% | -9.43% | -23.49% | -83.77% | +28.92% | -17.49% | -12.90% | +4.23% | -25.38% | -94.72% |
| 2021 | +9.31% | +16.51% | -13.77% | +18.76% | +2.38% | +21.62% | -15.56% | +14.29% | -9.88% | -16.43% | -15.71% | +1.05% | +0.54% |
| 2020 | +7.20% | -31.03% | -13.72% | +0% | -0% | +20.35% | +75.56% | -24.76% | -0.40% | +2.61% | +6.56% | +154.45% | +181.03% |
| 2019 | +9.99% | -31.52% | +13.32% | -16.40% | -20.60% | -14.09% | -30.11% | +33.20% | +57.47% | +5.56% | -57.50% | +43.73% | -53.99% |
| 2018 | +10.78% | -1.59% | -23.13% | +7.52% | +40.94% | -2.83% | -8.02% | +16.67% | -1.38% | +39.35% | -10.91% | -16.65% | +35.12% |
| 2017 | -19.85% | -14.70% | -23.14% | +1.04% | -4.56% | -1.07% | +9.66% | -14.17% | -9.07% | -47.38% | -8.56% | +44.18% | -70.24% |
Drawdown analysis of VistaGen Therapeutics (VTGN)
The maximum drawdown for the VTGN was -99.89%, occurring on Jun 30, 2026. This drawdown has not yet recovered.
The current VTGN drawdown is -99.89%.
Since May 6, 2016 VTGN has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 1 time
- 10% or more: 1 time
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.89% | May 6, 2016 | 2550 | Jun 30, 2026 | Ongoing | Ongoing | Ongoing |